Lixte Biotechnology Shares Rise 25% on LB-100 Cancer Treatment Research

By Denny Jacob Lixte Biotechnology Holdings on Monday said a collaboration with the Netherlands Cancer Institute showed that inhibition of an enzyme in colon...

Related Keywords

Netherlands ,Denny Jacob ,Lixte Biotechnology Holdings On ,Netherlands Cancer Institute ,Biotechnology Holdings ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Cancer Drugs ,Healthcare Life Sciences ,Specialized Drugs Medications ,Financial Performance ,Share Price Movement Disruptions ,Corporate Industrial News ,Cancer ,Political General News ,Health ,Medical Conditions ,Equity Markets ,Commodity Financial Market News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Us5393193017 ,Zblixt ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Political ,General News ,Commodity ,Financial Market News ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,